Back to search
FDAFDA · Food and drugs·Recall number Z-1556-2020

Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144

Published April 1, 2020 · Recall initiated: November 14, 2019

Summary

FDA records medical device Class II recall Z-1556-2020, published April 1, 2020 and initiated November 14, 2019. Recalling firm: Abbott Diabetes Care, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Not associated with specific model/lot numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abbott Diabetes Care, Inc.
Distributor
U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN
Lot
Not associated with specific model/lot numbers.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144 recalled?

Yes. FDA published recall Z-1556-2020 on April 1, 2020. Reported hazard: Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.

What should I do if I have this product?

Voluntary: Firm initiated · Letter